Article
[Treatment of chronic hepatitis viral C: new associations].
Presse medicale (Paris, France : 1983) - 1 Jun 2013
Ouzan Denis
Abstract excerpt
The current treatment of patients with chronic HCV infection since ten years is pegylated interferon combined with ribavirin. This association allows a virological eradication in 55% of patients, all genotype and 40% of those infected with genotype 1, the most prevalent. Two protease inhibitors (telaprevir and boceprevir) were approved in 2011, in combination with pegylated interferon and ribavirin in both naïve...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
